neurotransmitter
Showing 1 - 25 of 791
Fatigue Trial in Brussels (Reboxetine Pill, Methylphenidate Oral Product)
Recruiting
- Fatigue
- Reboxetine Pill
- Methylphenidate Oral Product
-
Brussels, BelgiumBrussels Labo voor Inspanning & Topsport U-residence
May 19, 2023
Brain Cancer Trial in Dallas (Hyperpolarized [13C]Pyruvate)
Recruiting
- Brain Cancer
- Hyperpolarized [13C]Pyruvate
-
Dallas, TexasUT Southwestern - Advanced Imaging Research Center
Oct 5, 2021
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Pain, Postoperative, Pain, Acute, Pain, Chronic Trial in Athens (lidocaine-magnesium infusion, lidocaine-ketamine infusion,
Recruiting
- Pain, Postoperative
- +10 more
- lidocaine-magnesium infusion
- +2 more
-
Athens, GreeceAretaieion University Hospital
Oct 25, 2022
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)
Recruiting
- Prader-Willi Syndrome
- +20 more
- Guanfacine Extended Release
- Placebo
-
Brooklyn, New YorkMaimonides Medical Center
Dec 20, 2022
Depression and Anxiety in Long Term Coronavirus Disease COVID-19
Not yet recruiting
- Covid19
- +2 more
- Depression
- Anxiety
-
Makasar, South Sulawesi, IndonesiaHasanuddin University Medical Research Center / HUMRC
Jun 3, 2021
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
-
Garden Grove, California
- +8 more
Nov 19, 2021
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156
Recruiting
- Schizophrenia
- +11 more
- LY03010 156 mg treatment group, deltoid
- +3 more
-
Little Rock, Arkansas
- +8 more
Apr 11, 2022
Skin Restricted Lupus, Psychiatric Disorders Trial in Clermont-Ferrand (Biological dosage from plasma)
Completed
- Skin Restricted Lupus
- Psychiatric Disorders
- Biological dosage from plasma
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Normal Physiology Trial run by the National Institute of Mental Health (NIMH) (3T and 7T device)
Recruiting
- Normal Physiology
- 3T and 7T device
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Stroke, Stroke Rehabilitation, Lower Extremity Weakness, Spastic Trial (High Intensity Interval Training (HIIT))
Not yet recruiting
- Stroke
- +3 more
- High Intensity Interval Training (HIIT)
- (no location specified)
Sep 22, 2023
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Trial in Dhaka (lidocaine transdermal patch)
Recruiting
- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
- lidocaine transdermal patch
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 22, 2023
Trigeminal Neuralgia Trial (trigminal nerve block with RFT)
Not yet recruiting
- Trigeminal Neuralgia
- trigminal nerve block with RFT
- (no location specified)
Jan 29, 2023
Cognition, Medically Intractable Epilepsy Trial in Phoenix (Behavioral testing under intracranial monitoring)
Enrolling by invitation
- Cognition
- Medically Intractable Epilepsy
- Behavioral testing under intracranial monitoring
-
Phoenix, ArizonaBanner - University Medical Center, Phoenix campus
Oct 25, 2022
Myofacial Pain Syndrome, Botulinum Toxin Trial in Cairo (Solvazinc 50mg, )
Enrolling by invitation
- Myofacial Pain Syndrome
- Botulinum Toxin
- Solvazinc 50mg
- placebo
-
Cairo, Manial, EgyptFaculty of Dentistry
Nov 3, 2022
Migraine, Omega-3 Polyunsaturated Fatty Acids Trial in Taichung (Omega-3 polyunsaturated fatty acids, omega-6 PUFAs)
Completed
- Migraine
- Omega-3 Polyunsaturated Fatty Acids
- Omega-3 polyunsaturated fatty acids
- omega-6 PUFAs
-
Taichung, TaiwanKuang Tien General Hospital
Jun 22, 2022
Acute Coronary Syndrome, Myocardial Ischemia Trial in Roma (Anamnesis and clinical evaluation)
Recruiting
- Acute Coronary Syndrome
- Myocardial Ischemia
- Anamnesis and clinical evaluation
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS di R
Mar 3, 2023
Zygomatic-temporal Neuroma Triggering Cluster Headache
Completed
- Cluster Headache
- Craniofacial Pain Syndrome
- Minimal surgical exploration for a neuroma
-
Corona, CaliforniaCorona Doctors Medical Clinics Inc
Nov 25, 2022
Learning; Lack of (Specific) Trial in Darwin (Effects of tDCS of dlPFC on Probabilistic Selection Task)
Recruiting
- Learning; Lack of (Specific)
- Effects of tDCS of dlPFC on Probabilistic Selection Task
-
Darwin, Northern Territory, AustraliaCharles Darwin University, College of Health & Human Sciences
Jul 26, 2021
Depression, Unipolar Trial (Intravenous Ketamine)
Not yet recruiting
- Depression, Unipolar
- Intravenous Ketamine
- (no location specified)
Aug 6, 2023
Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)
Recruiting
- Postmenopausal Symptoms
- +2 more
- Cholinergic antagonist
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Trauma, Nervous System Trial in Bozeman (Trauma)
Not yet recruiting
- Trauma, Nervous System
-
Bozeman, MontanaRoss Allison NPI #1437519899 Administrator Of Study
Feb 24, 2022
Epilepsy, Intermittent Fasting Trial in Marburg (IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm)
Recruiting
- Epilepsy
- Intermittent Fasting
- IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm
-
Marburg, Hessen, GermanyPhilipps University Marburg, Faculty of Medicine, Department of
Aug 24, 2023
Peripheral Serotonin and Albinism
Not yet recruiting
- Oculocutaneous Albinism
- Dosage of serotonin and metabolites
- Blood parameters
-
Paris, FranceHôpital Necker-Enfants Malades
Nov 14, 2023